# OnCo record oric-pharmaceuticals (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/oric-pharmaceuticals/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "oric-pharmaceuticals" ;
  schema:name "ORIC Pharmaceuticals"@en ;
  schema:description "ORIC Pharmaceuticals develops pills designed to beat the ways cancers resist treatment. One blocks a gene-silencing complex in prostate cancer; the other targets mutated EGFR and HER2 in lung cancer and can reach the brain."@en ;
  schema:url <https://onco.cc/companies/oric-pharmaceuticals/>, <https://oricpharma.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://oricpharma.com/>, <https://oricpharma.com/pipeline/>, <https://www.sec.gov/Archives/edgar/data/1796280/000156459020019302/oric-ex991_68.htm> ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/>, <https://onco.cc/fronts/epigenetics/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/epigenetic-drugs/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/ezh2/>, <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/rinzimetostat/> ;
  onco:trials <https://onco.cc/trials/nct05315700/> .